N/A
N=991
Evaluating Cancer Survivorship Care Models
Quality of Life · Cancer
Bottom Line
View on ClinicalTrials.gov: NCT02362750 ↗Enrolled (actual)
991
Serious AEs
0.0%
Results posted
Mar 2026
Primary outcome: Primary: Percentage of Survivors Reporting "Yes Definitely" Across Items Within Each of 9 Factors Reflecting Survivorship Care Quality — 33.1; 14.8; 30.7; 18.9 percentage of participants — p=<.05
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- Consultative Specialized Survivorship Clinic (CSSC) (Other); Longitudinal Specialized Survivorship Clinic (LSSC) (Other); Oncology Embedded Survivorship Clinic (OESC) (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- George Washington University
- Primary completion
- Oct 2016
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percentage of Survivors Reporting "Yes Definitely" Across Items Within Each of 9 Factors Reflecting Survivorship Care Quality |
33.1; 14.8; 30.7; 18.9; 20.2; 12.6 | <.05 sig |
| PRIMARY Average Number of Quality of Life Top Concerns Reported Converted to a Percentage |
56.5; 54.5; 52.6; 58.3; 50.7; 53.1 | <.05 sig |
| PRIMARY Self- Efficacy Score |
3.94; 3.89; 4.03; 4.26; 4.25; 4.26 | <.10 |
| PRIMARY Frequency of Visit |
.71; 1.0; .91; .77; .90; .76 | .001 sig |
Summary
The Evaluating Cancer Survivorship Care Models project is an innovative 3-year study that is collecting data to help understand how to best deliver follow-up care to cancer survivors. Cancer is a complex disease requiring complex treatments that can cause lasting impacts after treatment ends. Some patients face physical, psychosocial, spiritual and/or practical challenges as they adjust to life after cancer. Fortunately, health care providers have begun to focus on the consequences of cancer and its treatment and are more actively working with cancer survivors to manage post-treatment needs and care.
Led by the George Washington University and funded by the Patient-Centered Outcomes Research Institute, this project brings together representatives from the Commission on Cancer, the Cancer Support Community, LIVESTRONG and the American Cancer Society as well as cancer survivors and healthcare professionals to better understand how different strategies or models of care impact outcomes that are most important to cancer survivors. The project will focus on survivors of breast, prostate and colorectal cancers and will be relevant for understanding the needs and preferences of survivors of other cancers as well. The emphasis is on patient-centered outcomes, which are outcomes that are most significant to patients, such as patient satisfaction and quality of life.
Eligibility Criteria
Inclusion criteria
- English-speaking survivors of non-metastatic breast, prostate or colorectal cancers
- Completed active treatment (chemotherapy, radiation, and/or surgery), but may be on hormonal medication, aromatase inhibitors or other maintenance therapy
- Diagnosed at 18 years old or older
- First survivorship care appointment has been scheduled but not completed
- Be a patient at one of the high-performing cancer programs selected to participate in the CER study
Exclusion criteria
- Diagnosed with cancer other than breast, prostate or colorectal cancer
- Not English-speaking
- Currently undergoing active treatment (defined as chemotherapy, radiation, and/or surgery)
- Cancer has metastasized
- Diagnosed at under 18 years old
- Have completed first appointment with the survivorship program
- Not a patient at one of the high-performing cancer programs selected to participate in the CER study
Data sourced from ClinicalTrials.gov (NCT02362750). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.